Recruiting Pulmonary Hypertension Studies in Albuquerque
About Pulmonary Hypertension Clinical Trials in Albuquerque
Pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. It can lead to heart failure if untreated. Treatment includes vasodilators, endothelin receptor antagonists, and PDE-5 inhibitors.
There are currently 2 pulmonary hypertension clinical trials recruiting participants in Albuquerque, NM. These studies are seeking a combined 76 participants. Research is being sponsored by University of New Mexico, Pulmovant, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Hypertension Clinical Trials in Albuquerque — FAQ
Are there pulmonary hypertension clinical trials in Albuquerque?
Yes, there are 2 pulmonary hypertension clinical trials currently recruiting in Albuquerque, NM. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Albuquerque?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Albuquerque research site will contact you about next steps.
Are clinical trials in Albuquerque free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Albuquerque studies also compensate for your time and travel.
What pulmonary hypertension treatments are being tested?
The 2 active trials in Albuquerque are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary hypertension.
Data updated September 4, 2026 from ClinicalTrials.gov